Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab in chronic migraine with medication overuse headache
NCT03971071Phase 4Completed
- Sponsor
- Amgen
- Start
- Oct 2019
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 4 trial of erenumab in chronic migraine, sponsored by Amgen. Started Oct 2019; status: completed.
02
Drugs
erenumab
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT03971071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03971071.